McGwire gives up andro
St. Louis Cardinals home run star announces he stopped using the dietary supplement androstenedione four months ago. McGwire says he does not want to be portrayed as an endorser of the supplement. The supplement reached the height of publicity when McGwire announced he used andro to help recuperate from his training regimen. Subsequently, companies flooded the market with andro products. However, questions began to arise regarding the lack of clinical data supporting andro's steroidal effects and safety. In January, the ingredient was nominated for toxicity testing by the National Toxicology Program (1"The Tan Sheet" Jan. 4, p. 8)
More from Archive
More from Pink Sheet
While the pharma industry appears to be exempt from US tariffs imposed by President Trump, a member of the UK House of Lords says the details are unknown and warned that uncertainty “leads to less investment” in business as a whole.
The EU Clinical Trials Information System has achieved primary registry designation in the International Clinical Trials Registry Platform in a move that is expected to reduce regulatory burden for companies and help them lower compliance costs by aligning with publication requirements in medical journals.
The UK government has listened to industry concerns about high clawback rates under the voluntary scheme and will review it in June in a bid to resolve the issue and “move on to bigger and more important things,” health secretary Wes Streeting says.